期刊
DRUG DISCOVERY TODAY
卷 8, 期 8, 页码 356-363出版社
ELSEVIER SCI LTD
DOI: 10.1016/S1359-6446(03)02654-0
关键词
-
资金
- NIGMS NIH HHS [GM 61390] Funding Source: Medline
Resistance to antineoplastic drugs represents a serious obstacle to successful cancer treatment. Genome-wide studies correlating drug response phenotypes with large DNA/tissue microarray and proteomic datasets have been performed to identify the genes and proteins involved in chemosensitivity or drug resistance. The goal is to identify a set of chemosensitivity and/or resistance genes for each drug that are predictive of treatment response. Therefore, validated pharmacogenomic biomarkers offer the potential for the selection of optimal treatment regimens for individual patients and for identifying novel therapeutic targets to overcome drug resistance.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据